Small Modular ImmunoPharmaceuticals

Small Modular ImmunoPharmaceuticals, also knows as SMIPs, is novel class of drugs, a single-chain polypeptides, therapeutic antibodies. Being one third to half the size of corresponding monoclonal antibodies, they have similar in vivo half life and better tissue penetration properties.